Canada markets close in 1 hour 3 minutes

CloudMD Software & Services Inc. (DOC.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1100-0.0050 (-4.35%)
As of 02:41PM EST. Market open.
Full screen
Previous Close0.1150
Open0.1150
Bid0.1100 x N/A
Ask0.1150 x N/A
Day's Range0.1100 - 0.1200
52 Week Range0.1050 - 0.2500
Volume397,942
Avg. Volume168,528
Market Cap33.515M
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-0.2300
Earnings DateNov 30, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.42
  • GlobeNewswire

    CloudMD Reports Third Quarter 2023 Financial Results; Company Delivers Early on Commitment to be Adjusted EBITDA Positive

    Net Loss of $5.8 million, the fourth consecutive quarter of profitability improvementAdjusted EBITDA1 of $0.05 million, Adjusted EBITDA positive a quarter ahead of guidanceRevenue of $23.6 million, driven by 10% year over year organic growth on a normalized basis and $2.8 million in new ARR1 in the Health and Wellness divisionGross margin above 35% for the fourth consecutive quarterCash used in Operations of $3.5 million, Adjusted net cash used in operating activities1 $0.4 million, representing

  • GlobeNewswire

    CloudMD Announces Third Quarter Earnings Date

    VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, is pleased to announce that the Company will release its financial results for the third quarter of 2023 on November 29, 2023, after market. CloudMD will hold its Q3 2023 earnings conference call and webinar on November 30, 2023, at 9:30 am ET (6:30 am PT). T

  • GlobeNewswire

    CloudMD Updates Timing of Q3 Earnings

    VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), an innovative health services company transforming the delivery of care, today announced that the Company now expects to release its financial results for the period ended September 30, 2023 (“Q3 2023”) on or before November 29, 2023. The Company’s auditor, KPMG LLP, has requested additional time to complete its review procedures.